| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
126,890,000 |
| Market
Cap: |
1.15(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$9.05 - $9.1 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile CTI BioPharma is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies for blood-related cancers where there is an unmet medical need. Co. has one commercially approved product, VONJO™ (pacritinib), which has received approval in the U.S. by the U.S. Food and Drug Administration for the treatment of adult patients with intermediate or primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis with a platelet count below 50 x 10^9/L.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
5,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$27,500 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
0 |
0 |
9,850,628 |
| Total Sell Value |
$0 |
$0 |
$0 |
$60,226,858 |
| Total People Sold |
0 |
0 |
0 |
5 |
| Total Sell Transactions |
0 |
0 |
0 |
26 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Love Richard L |
Director |
– • – |
2013-12-17 |
4 |
S |
$1.71 |
$10,266 |
D/D |
(6,000) |
403,265 |
|
- |
|
| Baxter International Inc |
10% Owner |
– – • |
2013-11-25 |
4 |
OE |
$1.91 |
$30,000,000 |
D/D |
15,673,981 |
15,673,981 |
|
- |
|
| Bianco James A |
President and CEO |
• • – |
2013-09-23 |
4 |
AS |
$1.50 |
$195,435 |
D/D |
(130,551) |
1,483,797 |
|
- |
|
| Bianco James A |
President and CEO |
• • – |
2013-08-30 |
4 |
AS |
$1.08 |
$27,999 |
D/D |
(25,925) |
1,614,348 |
|
- |
|
| Bianco James A |
President and CEO |
• • – |
2013-08-09 |
4 |
S |
$1.07 |
$42,800 |
D/D |
(40,000) |
1,640,273 |
|
- |
|
| Mundinger Mary Oneil |
Director |
– • – |
2013-08-07 |
4 |
S |
$1.05 |
$132,549 |
D/D |
(125,000) |
220,335 |
|
- |
|
| Nudelman Phillip M Phd |
Director |
– • – |
2013-08-06 |
4 |
S |
$1.09 |
$54,507 |
D/D |
(50,000) |
329,619 |
|
- |
|
| Bianco James A |
President and CEO |
• • – |
2013-07-26 |
4 |
AS |
$1.09 |
$28,000 |
D/D |
(25,688) |
1,680,273 |
|
- |
|
| Nudelman Phillip M Phd |
Director |
– • – |
2013-06-26 |
4 |
A |
$0.00 |
$0 |
D/D |
108,696 |
379,619 |
|
- |
|
| Love Richard L |
Director |
– • – |
2013-06-26 |
4 |
A |
$0.00 |
$0 |
D/D |
86,957 |
409,265 |
|
- |
|
| Mundinger Mary Oneil |
Director |
– • – |
2013-06-26 |
4 |
A |
$0.00 |
$0 |
D/D |
86,957 |
345,335 |
|
- |
|
| Gregorian Vartan |
Director |
– • – |
2013-06-26 |
4 |
A |
$0.00 |
$0 |
D/D |
86,957 |
404,937 |
|
- |
|
| Singer Jack W |
EVP, Global Medical Affairs |
• • – |
2013-06-05 |
4 |
S |
$1.26 |
$12,600 |
D/D |
(10,000) |
701,035 |
|
- |
|
| Bianco James A |
President and CEO |
• • – |
2013-05-31 |
4 |
S |
$1.22 |
$34,104 |
D/D |
(28,000) |
1,732,014 |
|
- |
|
| Bianco Louis A |
EVP, Finance & Administration |
• – – |
2013-05-31 |
4 |
S |
$1.22 |
$41,670 |
D/D |
(33,712) |
553,698 |
|
- |
|
| Telling Fred |
Director |
– • – |
2013-05-30 |
4 |
S |
$1.22 |
$80,102 |
D/D |
(64,798) |
240,308 |
|
- |
|
| Bianco James A |
President and CEO |
• • – |
2013-05-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
17,000 |
1,760,014 |
|
- |
|
| Love Richard L |
Director |
– • – |
2013-05-24 |
4 |
S |
$1.21 |
$27,853 |
D/D |
(23,000) |
322,308 |
|
- |
|
| Bianco James A |
President and CEO |
• • – |
2013-05-10 |
4 |
S |
$1.16 |
$20,898 |
D/D |
(18,000) |
1,777,014 |
|
- |
|
| Bianco Louis A |
EVP, Finance & Administration |
• – – |
2013-05-09 |
4 |
S |
$1.14 |
$57,346 |
D/D |
(50,000) |
587,410 |
|
- |
|
| Bianco James A |
President and CEO |
• • – |
2013-05-08 |
4 |
S |
$1.16 |
$8,106 |
D/D |
(7,000) |
1,795,014 |
|
- |
|
| Bianco Louis A |
EVP, Finance & Administration |
• – – |
2013-03-21 |
4 |
A |
$0.00 |
$0 |
D/D |
296,705 |
637,410 |
|
- |
|
| Bianco Louis A |
EVP, Finance & Administration |
• – – |
2013-03-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(68,174) |
340,705 |
|
- |
|
| Singer Jack W |
EVP, Global Medical Affairs |
• • – |
2013-03-21 |
4 |
A |
$0.00 |
$0 |
D/D |
296,705 |
711,035 |
|
- |
|
| Singer Jack W |
EVP, Global Medical Affairs |
• • – |
2013-03-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(68,174) |
414,330 |
|
- |
|
742 Records found
|
|
Page 11 of 30 |
|
|
